Form 6-K NaaS Technology Inc. For: Aug 05

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2026

 

Commission File Number: 001-38235

 

NaaS Technology Inc.

(Registrant’s Name)

 

Newlink Center, Area G, Building 7, Huitong Times Square,

No.1 Yaojiayuan South Road, Chaoyang District, Beijing, China

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒     Form 40-F ☐

 

 

 

Information Contained in this Report on Form 6-K

 

On August 4, 2026, NaaS Technology Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it has regained compliance with Nasdaq’s Listing Rule 5550(b)(2), and the matter is now closed.

 

The Company issued a press release relating to the foregoing, which is attached to this Form 6-K as Exhibit 99.1.

 

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		NaaS Technology Inc. Regains Compliance with Nasdaq Minimum Market Value of Listed Securities Requirement

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	NaaS Technology Inc.
	By:	/s/ Steven Sim
	Name:	Steven Sim
	Title:	Chief Financial Officer

 

Date: August 5, 2026

 

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• China Has Become Colombia's Reliable Partner in Times of Uncertainty
• HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Can
• XRP Price Prediction: Can $2 Return as AlphaPepe Stage 20 Buyers Position for What August 19 Could Reveal?